 Bone Neoplasms
"Bone Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumors or cancer located in bone tissue or specific BONES.
| Descriptor ID |
D001859
|
| MeSH Number(s) |
C04.588.149 C05.116.231
|
| Concept/Terms |
Bone Neoplasms- Bone Neoplasms
- Bone Neoplasm
- Neoplasm, Bone
- Neoplasms, Bone
|
Below are MeSH descriptors whose meaning is more general than "Bone Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Bone Neoplasms".
This graph shows the total number of publications written about "Bone Neoplasms" by people in this website by year, and whether "Bone Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 0 | 1 | | 1998 | 1 | 0 | 1 | | 1999 | 1 | 2 | 3 | | 2000 | 0 | 1 | 1 | | 2001 | 1 | 1 | 2 | | 2002 | 2 | 0 | 2 | | 2003 | 4 | 0 | 4 | | 2004 | 2 | 0 | 2 | | 2005 | 2 | 0 | 2 | | 2006 | 4 | 2 | 6 | | 2007 | 3 | 1 | 4 | | 2008 | 3 | 0 | 3 | | 2009 | 5 | 2 | 7 | | 2010 | 6 | 1 | 7 | | 2011 | 4 | 2 | 6 | | 2012 | 9 | 2 | 11 | | 2013 | 6 | 0 | 6 | | 2014 | 5 | 2 | 7 | | 2015 | 12 | 3 | 15 | | 2016 | 6 | 0 | 6 | | 2017 | 11 | 3 | 14 | | 2018 | 5 | 1 | 6 | | 2019 | 4 | 1 | 5 | | 2020 | 3 | 2 | 5 | | 2021 | 9 | 0 | 9 | | 2022 | 11 | 0 | 11 | | 2023 | 9 | 0 | 9 | | 2024 | 9 | 5 | 14 | | 2025 | 3 | 0 | 3 |
To return to the timeline, click here.
Below are the most recent publications written about "Bone Neoplasms" by people in Profiles.
-
Goodspeed A, Bodlak A, Duffy AB, Nelson-Taylor S, Oike N, Porfilio T, Shirai R, Walker D, Treece A, Black J, Donaldson N, Cost C, Garrington T, Greffe B, Luna-Fineman S, Demedis J, Lake J, Danis E, Verneris MR, Adams DL, Hayashi M. Single-Cell RNA Sequencing of Ewing Sarcoma Tumors Demonstrates Transcriptional Heterogeneity and Clonal Evolution. Clin Cancer Res. 2025 May 15; 31(10):2010-2023.
-
Biermann JS, Hirbe A, Ahlawat S, Bernthal NM, Binitie O, Boles S, Brigman B, Callan AK, Cipriano C, Cranmer LD, Davis J, Donnelly E, Ferguson M, Graham A, Groundland J, Hess M, Hiniker SM, Hoover-Regan ML, Hornick JL, Jonard B, Kuechle JB, Lindskog D, Mayerson JL, McGarry SV, Morris CD, Olson D, Rose PS, Santana VM, Satcher RL, Schwartz H, Shulman RM, Thorpe SW, Wilky BA, Wustrack RL, Yoon J, Hang LE, Jones F, Sansone N, Lyons M. Bone Cancer, Version 2.2025, NCCN Clinical Practice Guidelines In Oncology. J Natl Compr Canc Netw. 2025 04; 23(4).
-
Ravi P, Jasuja H, Sarkar D, Vahidi Pashaki B, Gaikwad HK, Vahidi Pashaki P, Katti DR, Shetty K, Katti KS. Rhodiola crenulata induces apoptosis in bone metastatic breast cancer cells via activation of caspase-9 and downregulation of MtMP activity. Sci Rep. 2025 Mar 18; 15(1):9341.
-
Dhir A, Hayashi M, Bodlak A, Oesterheld J, Loeb DM, Mascarenhas L, Isakoff MS, Sandler ES, Borinstein SC, Trucco M, Lagmay JP, Setty BA, Pratilas CA, Caywood E, Metts J, Yin H, Fridley B, Yin J, Laborde J, Reed DR, Adams DL, Wagner LM. Phase II Trial of Gemcitabine and Nab-Paclitaxel for Recurrent Osteosarcoma with Serial Monitoring Using Liquid Biopsy: A Report from the National Pediatric Cancer Foundation. Clin Cancer Res. 2024 Dec 02; 30(23):5314-5322.
-
Casey DL, Murphy ES, Shen CJ, Milgrom SA, Larrier NA, Bradley JA, Ladra MM, Indelicato DJ, Hill-Kayser CE, Borinstein SC, Luo LY. Metastatic-Site Radiation Therapy for Ewing Sarcoma and Rhabdomyosarcoma: Consensus Guidelines From the National Pediatric Cancer Foundation. Pract Radiat Oncol. 2025 Mar-Apr; 15(2):180-186.
-
McLean-Thomas L, Fakhoury K, Ross RB, Mahoney R, Gortmaker N, Hu J, Karam SD. Prospective surveillance of patients after palliative radiation for painful bone metastases: a feasibility study. Ann Palliat Med. 2024 Sep; 13(5):1202-1209.
-
Schloemer NJ, Xue W, Qumseya A, Luo LY, Hiniker SM, Lautz TB, Rhee DS, Arnold MA, Venkatramani R. Children and young adults with newly diagnosed rhabdomyosarcoma metastatic to bone treated on Children's Oncology Group studies. Pediatr Blood Cancer. 2024 Oct; 71(10):e31200.
-
Meyers PA, Federman N, Daw N, Anderson PM, Davis LE, Kim A, Macy ME, Pietrofeso A, Ratan R, Riedel RF, Trucco M, Breitmeyer JB, Toretsky JA, Ludwig JA. Open-Label, Multicenter, Phase I/II, First-in-Human Trial of TK216: A First-Generation EWS::FLI1 Fusion Protein Antagonist in Ewing Sarcoma. J Clin Oncol. 2024 Nov; 42(31):3725-3734.
-
Whiteley AE, Ma D, Wang L, Yu SY, Yin C, Price TT, Simon BG, Xu KR, Marsh KA, Brockman ML, Prioleau TM, Zhou KI, Cui X, Fecci PE, Jeck WR, McCall CM, Neff JL, Sipkins DA. Breast cancer exploits neural signaling pathways for bone-to-meninges metastasis. Science. 2024 06 21; 384(6702):eadh5548.
-
Shirai R, Biebighauser T, Walker D, Oviedo J, Nelson-Taylor S, Bodlak A, Porfilio T, Oike N, Goodspeed A, Hayashi M. Cadherin-11 contributes to the heterogenous and dynamic Wnt-Wnt-?-catenin pathway activation in Ewing sarcoma. PLoS One. 2024; 19(6):e0305490.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|